ISRWF:OTC-iShares II Public Limited Company - iShares J.P. Morgan $ Emerging Markets Bond UCITS ETF (USD)

ETF | Others |

Last Closing

USD 89.5752

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.32K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

N/A

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
EBCRY EBCRY

N/A

USD 3.26B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
IFXAF iShares Asia Trust - iShares F..

N/A

USD 2.94B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

N/A

USD 2.22B

ETFs Containing ISRWF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.72% 19% F 55% F
Dividend Return 3.52% 72% C 58% F
Total Return 5.23% 40% F 58% F
Trailing 12 Months  
Capital Gain 7.38% 33% F 63% D
Dividend Return 4.72% 79% B- 61% D-
Total Return 12.10% 45% F 65% D
Trailing 5 Years  
Capital Gain -21.67% 11% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.67% 11% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain -5.29% N/A N/A 29% F
Dividend Return -3.89% N/A N/A 28% F
Total Return 1.40% N/A N/A 29% F
Risk Return Profile  
Volatility (Standard Deviation) 11.79% N/A N/A 95% A
Risk Adjusted Return -33.02% N/A N/A 20% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike